Genetic Technologies Ltd - American Depositary Shares (GENE) analyst actions
Rating and price-target actions on GENE in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the GENE overview →
No GENE analyst action events in the measured window.
Nothing matched in the current window — the GENE overview has every event we measure for this name.
Get an email when GENE moves on news →Keep exploring
More GENE: earnings → · SEC filings → · GENE overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Orchard Therapeutics plc - American Depositary Shares (ORTX) | 80 | +0.06% | 66% |
| Elite Pharmaceuticals, Inc. (ELTP) | 79 | -0.11% | 42% |
| MOTIF BIO PLC ADRS (MTFB) | 79 | 0.00% | 39% |
| Affimed N.V. (AFMD) | 78 | -2.06% | 27% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.